Cloning technologies deliver a surprisingly broad set of benefits across science and medicine, from creating patient-matched stem cells that could sidestep organ rejection to bringing endangered species back from the genetic brink. The term “cloning” itself covers more ground than most people realize, encompassing everything from growing identical plant shoots in a lab to transferring the nucleus of one animal cell into an emptied egg cell to produce a genetically identical organism. Many of the most promising applications are already moving out of the experimental stage and into real-world use, while others remain works in progress with enormous potential.
Patient-Matched Stem Cells
One of the clearest medical benefits of cloning lies in its ability to generate stem cells that are a genetic match to an individual patient. The technique, called somatic cell nuclear transfer (SCNT), takes the nucleus from a patient’s own cell, places it into a donated egg cell whose nucleus has been removed, and coaxes that combined cell to develop into an early-stage embryo. From that embryo, researchers can harvest embryonic stem cells that carry the patient’s DNA. Because those stem cells are genetically matched, tissues grown from them are far less likely to trigger an immune rejection if transplanted back into the patient.
This concept moved from theory to practice in 2013, when a research team successfully derived human embryonic stem cells through SCNT for the first time. The resulting cells behaved like stem cells derived from ordinary embryos: they could turn into a wide variety of tissue types, and their gene-expression profiles were comparable.1PubMed Central. Human embryonic stem cells derived by somatic cell nuclear transfer That breakthrough opened the door to the idea of personalized regenerative medicine, where replacement tissues for conditions like heart disease, spinal cord injury, or macular degeneration could be grown from a patient’s own genetic material.
There is another reprogramming method, called induced pluripotent stem cells (iPSCs), which achieves something similar without using egg cells at all. But SCNT-derived stem cells may carry an advantage: some researchers believe the nuclear-transfer process resets the cell’s epigenetic marks more completely than iPSC reprogramming does, potentially producing cells that behave more faithfully like natural embryonic stem cells.2Cell Stem Cell. Human SCNT: What Does It Mean for the Stem Cell Field? Whether that difference translates into a real clinical edge is still being investigated, but having two distinct routes to patient-matched stem cells gives researchers more flexibility.
Better Animal Models for Human Disease
Cloning has quietly transformed how scientists study diseases that affect humans. For decades, genetically engineered mice served as the default stand-in for testing treatments and understanding disease progression. Mice are cheap and reproduce quickly, but their bodies do not always mirror human biology closely enough. A striking example is cystic fibrosis: mice engineered with the same genetic mutation that causes the disease in people never developed the lung and digestive symptoms that make it devastating in humans. Pigs carrying that same mutation, however, did develop those symptoms, making them far more useful for studying the disease and testing potential therapies.3Animal Frontiers. Advancements in somatic cell nuclear transfer and future perspectives
Creating those pig models relies on cloning. Scientists first edit the desired mutation into pig cells grown in the lab, then use SCNT to produce live piglets carrying the engineered change. This approach works for a range of conditions beyond cystic fibrosis, including cardiovascular disease, diabetes, and neurodegenerative disorders. Because pigs share a similar body size, organ structure, and lifespan with humans, they often produce results that translate more reliably to human medicine than rodent studies can.
Moving Toward Transplantable Organs from Pigs
The shortage of donor organs kills thousands of people on waiting lists every year, and cloning is central to one of the most ambitious solutions: xenotransplantation, or transplanting organs from animals into humans. Pig organs are roughly the right size for human recipients, but unmodified pig tissue triggers a violent immune reaction. Cloning enables scientists to create pigs with precise genetic modifications that dial down the immune conflict. Some of these modifications knock out pig genes that produce molecules the human immune system attacks; others add human genes that help the transplanted organ look less foreign to the recipient’s body.4PubMed Central. Genetically Modified Pigs as Organ Donors for Xenotransplantation
One concern in this field is the risk of transmitting pig viruses to human recipients. Researchers use cloning from carefully screened donor cells partly to control the genetic background of the animals and reduce pathogen risk, though the danger is not entirely eliminated.5PubMed. Risk of pathogenic virus transmission by somatic cell nuclear transfer: implications for xenotransplantation Specialized miniature pig breeds raised in pathogen-free environments are also being developed through SCNT to serve as cleaner organ donors.6PubMed. Gnotobiotic Miniature Pig Interbreed Somatic Cell Nuclear Transfer for Xenotransplantation The first pig-to-human heart and kidney transplants performed in recent years relied on multi-gene-edited pigs produced through cloning technology, bringing what was once a distant sci-fi scenario into clinical reality.
Pharmaceutical Proteins from Transgenic Animals
Some of the most complex drugs used in medicine are proteins that are difficult and expensive to manufacture in traditional cell-culture factories. Cloning offers an alternative: engineer an animal so that its mammary glands produce the desired protein in its milk, then collect the milk and purify the drug. This approach works because mammary glands are naturally built to synthesize, fold, and secrete large quantities of protein, so the resulting drug molecules tend to be properly shaped and functional.7PubMed. Recombinant protein expression in milk of livestock species
Transgenic pigs, goats, and rabbits have been cloned to produce human proteins this way. In one early example, cloned pigs produced human protein C, a blood-clotting regulator used to treat patients with severe sepsis, at concentrations that made commercial-scale collection practical.8PubMed. Recombinant human protein C expression in the milk of transgenic pigs and the effect on endogenous milk immunoglobulin and transferrin levels The first approved drug made in a transgenic animal’s milk, an anticoagulant produced in goat milk, reached the market over a decade ago. Cloning is what makes these production herds economically viable, since it lets companies replicate their best-producing animals reliably instead of waiting generations for conventional breeding to deliver consistent results.
Human Antibodies from Cloned Cattle
A related but distinct pharmaceutical use involves cloned cattle engineered to carry human antibody genes. These “transchromosomic” cattle have a human artificial chromosome inserted into their cells, which allows their immune systems to produce fully human antibodies in response to vaccinations. Researchers clone cattle from these engineered cells, vaccinate the resulting animals against a target pathogen, and then harvest the human antibodies from the cattle’s blood.9PubMed. Cloned transchromosomic calves producing human immunoglobulin
This platform has been tested against some of the most dangerous infectious diseases on the planet. When researchers vaccinated these cattle against Zika virus and gave the resulting antibodies to infected mice, the treatment prevented lethal infection and eliminated virus-induced tissue damage, including in the brain and testes.10PubMed. Human polyclonal antibodies produced in transchromosomal cattle prevent lethal Zika virus infection and testicular atrophy in mice In a study targeting Ebola virus, antibodies from these cattle provided partial protection in primates, achieving a 50% survival rate following a lethal dose of the virus.11PubMed Central. Human Polyclonal Antibodies Produced by Transchromosomal Cattle Provide Partial Protection Against Lethal Zaire Ebolavirus Challenge in Rhesus Macaques The speed of this system is part of its appeal: new antibodies can be generated in weeks by simply vaccinating the cattle against a new pathogen, making it a potential rapid-response tool for emerging outbreaks.
Rescuing Endangered and Extinct Species
Conservation cloning has graduated from a theoretical concept to something that is actually saving species. The two landmark cases are the Przewalski’s horse and the black-footed ferret, both critically endangered animals that have been successfully cloned from cells frozen decades ago.
Przewalski’s horse, the last truly wild horse species, went through a severe population bottleneck that left the surviving herd dangerously inbred. By cloning from historically cryopreserved cells, researchers produced two healthy foals carrying genetic material that had been lost from the living population, effectively injecting new diversity back into the gene pool.12PubMed Central. Endangered Przewalski’s Horse, Equus przewalskii, Cloned from Historically Cryopreserved Cells The black-footed ferret effort followed a similar logic. A female that died in 1988 with no living descendants was cloned from frozen cells, producing three healthy kits. If these clones reproduce, they would add what amounts to a new founder lineage to a breeding program that currently traces back to only seven ancestors.13bioRxiv. First endangered black-footed ferrets, Mustela nigripes, cloned for genetic rescue These programs represent the first time cloning has been applied to conservation with measurable genetic benefit.14PubMed Central. Towards Practical Conservation Cloning: Understanding the Dichotomy Between the Histories of Commercial and Conservation Cloning
An even more dramatic case involved the bucardo, a subspecies of Spanish wild goat that went extinct in 2000. Researchers had frozen skin cells from the last living animal, and in 2003 they used those cells to produce a clone via cross-species SCNT, using domestic goat eggs and surrogate mothers. A genetically verified bucardo kid was born by cesarean section, making it the first animal ever born from an extinct subspecies.15PubMed. First birth of an animal from an extinct subspecies (Capra pyrenaica pyrenaica) by cloning The kid survived only minutes due to a lung defect, but the experiment proved the principle that extinction does not have to be permanent if cells are preserved in time.
The limiting resource in all of these efforts is frozen cell banks. Organizations like the San Diego Zoo’s Frozen Zoo have been cryopreserving cells from hundreds of species for decades, and those stockpiles are now being recognized as a genetic insurance policy. Researchers have generated stem cell lines from nine genetically distinct northern white rhinoceroses, a species with only two living individuals left, using cells stored in such biobanks.16PubMed Central. Rewinding Extinction in the Northern White Rhinoceros: Genetically Diverse Induced Pluripotent Stem Cell Bank for Genetic Rescue The long-term hope is that stem cell technology and cloning together can eventually produce eggs and sperm from preserved cells, allowing species to be repopulated from frozen material alone.17PubMed Central. Resurrecting biodiversity: advanced assisted reproductive technologies and biobanking
Preventing Inherited Mitochondrial Disorders
Cloning-adjacent techniques are also finding applications in human reproductive medicine. Mitochondrial replacement therapy (MRT) borrows the core idea behind nuclear transfer: take the nuclear DNA from one cell and place it into another cell whose own nucleus has been removed. In this case, the goal is to allow a woman whose mitochondria carry disease-causing mutations to have a genetically related child without passing those mutations along. The mother’s nuclear DNA is transferred into a donor egg with healthy mitochondria, and the resulting embryo carries its mother’s nuclear genes but the donor’s mitochondrial DNA.18Heliyon. What Are the Pros of Cloning? Benefits in Science & Medicine
Mitochondrial diseases can cause devastating neurological problems, organ failure, and early death. Because mitochondria are passed only through the mother, MRT breaks that chain of transmission. The first baby born through one of these techniques was reported in 2016, and a small number of countries have since legalized the procedure. The technique remains controversial in some quarters, since the resulting child technically has DNA from three people, but for families carrying severe mitochondrial mutations, it may be the only path to a healthy biological child.
Multiplying Elite Livestock Genetics
In agriculture, cloning serves a more straightforward purpose: making exact copies of animals with exceptional traits. An elite dairy cow that produces significantly more milk than her herd mates, or a bull with unusually desirable meat quality, can be cloned so that her or his genetics spread through a commercial population much faster than conventional breeding allows.19PubMed. Application of zona-free cloning technologies to livestock breeding programmes Cloned animals themselves often serve as breeding stock rather than entering the food supply directly, so their value lies in accelerating genetic improvement across an entire herd over just a few generations.
This approach has been most heavily adopted in beef cattle and dairy operations in countries like Brazil and Argentina, where the economics of large-scale ranching make the per-animal cost of cloning easier to justify. Horse cloning, particularly of elite polo ponies and show jumpers, has also become a niche commercial practice.
Cloned Working Dogs That Outperform
Training a dog to reliably detect drugs, explosives, or other contraband is expensive and has a high washout rate. Most puppies that enter detection-dog training programs never qualify. Cloning offers a way around this bottleneck by copying dogs that have already proven exceptional on the job. South Korean researchers cloned puppies from an elite drug-detection dog and found that the cloned puppies were selected as qualified detector dogs at a rate of about 86%, compared to roughly 30% for naturally bred puppies.20Behavior Genetics. Behavioral Analysis of Cloned Puppies Derived from an Elite Drug-Detection Dog Reviews of cloned working-dog programs have also found the cloned animals to be healthy and temperamentally similar to their genetic donors, though individual variation in behavior still exists since environment and training also shape a dog’s abilities.21PubMed Central. Health and temperaments of cloned working dogs
Disease-Free Plants Through Micropropagation
Cloning is not limited to animals. In agriculture and horticulture, plant cloning through tissue culture, often called micropropagation, is one of the most widely used and commercially successful forms of cloning in existence. The technique takes a tiny piece of plant tissue, typically from a shoot tip or meristem, and grows it in a sterile nutrient medium to produce hundreds or thousands of genetically identical plantlets. Because the starting tissue is taken from the growing tip above any sites of infection, the resulting plants are typically free of viruses and other pathogens that plague field-grown stock.22PLANT CELL BIOTECHNOLOGY AND MOLECULAR BIOLOGY. Advances in Micropropagation and Tissue Culture for Horticultural Crops: A Review
Potatoes are a classic example. Potato crops worldwide are vulnerable to viral diseases that accumulate in tubers over successive planting seasons, degrading yields. In vitro micropropagation from disease-free shoot tips allows growers to restart with clean material. Studies have shown that potato cultivars propagated this way can achieve shoot formation rates above 95% under the right hormone treatments.23Jammu Kashmir Journal of Agriculture. Effects of Plant Growth Regulators on in Vitro Micropropagation of Disease-Free Potato The same principle applies broadly to ginger, bananas, sugarcane, ornamental flowers, and many fruit trees.24Australian Journal of Crop Science. Micropropagation of three ginger cultivars and the subsequent growth and rhizome yield assessment and phytochemical composition analysis For crops that are propagated vegetatively rather than by seed, micropropagation is often the only practical way to mass-produce pathogen-free planting material at commercial scale.
Making Cloning Itself Work Better
A persistent obstacle in animal cloning is inefficiency. In many species, fewer than 5% of cloned embryos transferred to surrogate mothers result in live births. Much of this failure stems from incomplete reprogramming: when a differentiated adult cell’s nucleus is placed into an egg, the egg has to strip away the adult gene-expression patterns and reset the cell to a state where it can build an entire organism. Chemical marks on the DNA’s packaging proteins, particularly a modification called H3K9me3, tend to persist stubbornly and block genes from reactivating properly.25PubMed Central. Embryonic development following somatic cell nuclear transfer impeded by persisting histone methylation
Researchers have attacked this problem from several angles. Injecting enzymes that remove those stubborn marks has dramatically improved reprogramming in both mouse and human SCNT experiments.26PubMed. Histone Demethylase Expression Enhances Human Somatic Cell Nuclear Transfer Efficiency and Promotes Derivation of Pluripotent Stem Cells In pig cloning specifically, treating embryos with chemical compounds that loosen the DNA packaging roughly tripled the rate of blastocyst formation compared to untreated controls and improved the number of live births from surrogate mothers.27PubMed. Histone deacetylase inhibitor significantly improved the cloning efficiency of porcine somatic cell nuclear transfer embryos These technical improvements matter because every application described above, from patient-matched stem cells to conservation cloning, becomes more practical as the success rate rises and the cost per viable clone drops.
Understanding How Cells Remember What They Are
Beyond its practical applications, cloning has been one of the most powerful tools for studying a fundamental question in biology: how does a cell “know” what type of cell it is, and can that identity be erased? Every cell in your body carries the same DNA, yet a liver cell behaves nothing like a neuron. The differences are maintained by epigenetic marks, chemical tags on the DNA and its packaging that determine which genes are switched on or off in each cell type. Cloning by nuclear transfer essentially forces an adult cell to forget its identity and start over, making it one of the few experimental systems that lets scientists observe epigenetic reprogramming in real time.28PubMed. Reprogramming of epigenetic inheritance by somatic cell nuclear transfer
Studying why some cells reprogram successfully and others do not has revealed insights about aging, cancer, and development that extend well beyond cloning itself. Cancer cells, for instance, also undergo large-scale epigenetic changes that let them ignore the normal rules of cell behavior. Understanding the mechanisms that strip away or impose those marks during cloning feeds directly into research on why tumors form and how they might be stopped. The basic-science payoff of cloning research, in other words, reaches further than any single medical or agricultural application.